The recognized tumor markers for monitoring pancreatic cancer (PC) patients include measuring serum concentrations of carcinoembryonic antigen (CEA) or carbohydrate antigen 19-9 (CA 19-9) [33]. This evidence concerns the gene CEACAM5 and familial pancreatic carcinoma.